Get started
Author

András Vorobcsuk

Observed names: A Vorobcsuk, A. Vorobcsuk, Andras Vorobcsuk, Vorobcsuk Andras
ORCID: 0000-0002-6884-3130
Observed ORCID: 0000-0002-6884-3130
OpenAlex ID: A5077206214
Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: Systematic review and meta-analysis
2010 · Dániel Aradi, András Komócsi, et al. · American Heart Journal · 211
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction
2022 · Sunil V. Rao, Bodo Kirsch, et al. · Circulation · 182
PDF
Transradial versus transfemoral percutaneous coronary intervention in acute myocardial infarction
2009 · András Vorobcsuk, Attila Kónyi, et al. · American Heart Journal · 154
The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies
2012 · András Komócsi, András Vorobcsuk, et al. · Rheumatology · 143
Subcutaneous Versus Transvenous Implantable Defibrillator Therapy
2017 · Indranill Basu-Ray, Jing Liu, et al. · JACC. Clinical electrophysiology · 116
PDF
Optimizing P2Y12 Receptor Inhibition in Patients With Acute Coronary Syndrome on the Basis of Platelet Function Testing
2014 · Dániel Aradi, Adrienn Tornyos, et al. · Journal of the American College of Cardiology · 92
Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an Acute Coronary Syndrome: Systematic Review and Meta-analysis of Randomized Controlled Trials
2012 · András Komócsi, András Vorobcsuk, et al. · Archives of Internal Medicine · 79
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial
2021 · Subodh Verma, Nitish K Dhingra, et al. · The Lancet Diabetes & Endocrinology · 55
Effect of baxdrostat on ambulatory blood pressure in patients with resistant hypertension (Bax24): a phase 3, randomised, double-blind, placebo-controlled trial
2026 · Michel Azizi, Jenifer M Brown, et al. · The Lancet · 51
Impact of clopidogrel and potent P2Y12-inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: A systematic review and meta-analysis
2012 · András Komócsi, András Vorobcsuk, et al. · Thrombosis and Haemostasis · 48
Meta-Analysis Comparing Carvedilol Versus Metoprolol for the Prevention of Postoperative Atrial Fibrillation Following Coronary Artery Bypass Grafting
2013 · James J. DiNicolantonio, Craig J. Beavers, et al. · The American Journal of Cardiology · 41
Justification of 150 mg clopidogrel in patients with high on‐clopidogrel platelet reactivity
2011 · Dániel Aradi, Orsolya Rideg, et al. · European Journal of Clinical Investigation · 41
Biodegradable-Polymer or Durable-Polymer Stents in Patients at High Bleeding Risk: A Randomized, Open-Label Clinical Trial
2023 · Marco Valgimigli, Adrian Wlodarczak, et al. · Circulation · 24
PDF
Mechanism of coronary flow reserve reduction in systemic sclerosis: insight from intracoronary pressure wire studies
2010 · T. Pinter, R. Faludi, et al. · Rheumatology · 20
Low platelet disaggregation predicts poor response to 150 mg clopidogrel in patients with elevated platelet reactivity
2009 · Dániel Aradi, András Vorobcsuk, et al. · Platelets · 19
Successful endovascular treatment of simultaneous acute ischaemic stroke and hyperacute ST-elevation myocardial infarction: the first case report of a single-operator cardio-cerebral intervention
2021 · Sándor Nardai, András Vorobcsuk, et al. · European Heart Journal - Case Reports · 18
PDF
Systematic review/Meta-analysis Meta-analysis of randomized trials on access site selection for percutaneous coronary intervention in ST-segment elevation myocardial infarction
2014 · András Komócsi, Dániel Aradi, et al. · Archives of Medical Science · 18
PDF
Outcomes of patients receiving clopidogrel prior to cardiac surgery
2010 · András Vorobcsuk, Dániel Aradi, et al. · International Journal of Cardiology · 18
Comparison of conventional aggregomerty with VASP for monitoring P2Y12-specifc platelet inhibition
2010 · Dániel Aradi, Tamás Magyarlaki, et al. · Platelets · 18
Apixaban and risk of myocardial infarction: meta-analysis of randomized controlled trials
2014 · Adrienn Tornyos, András Vorobcsuk, et al. · Journal of Thrombosis and Thrombolysis · 10
Clinical outcomes in patients treated for coronary in-stent restenosis with drug-eluting balloons: Impact of high platelet reactivity
2017 · Adrienn Tornyos, Dániel Aradi, et al. · PLoS ONE · 5
PDF
Transradial percutaneous coronary intervention in acute myocardial infarction
2010 · András Komócsi, A. Vorobcsuk, et al. · Interventional Medicine and Applied Science · 5
Optimizing P2y12–receptor Inhibition in Acute Coronary Syndrome Patients After Pci Using Platelet Function Testing: Impact of Prasugrel Versus High–dose Clopidogrel
2013 · Daniel Aradi, Tunde Pinter, et al. · Journal of the American College of Cardiology · 4
PDF
dP /dtmax: An underestimated prognostic factor in large animal infarction model
2024 · Rita Garamvölgyi, Dénes Kőrösi, et al. · Animal Models and Experimental Medicine · 3
PDF
Diagnostic pitfalls: intramyocardial lymphoma metastasis mimics acute coronary syndrome in a diffuse large B cell lymphoma patient—case report
2021 · Lilla Prenek, Klára Csupor, et al. · International Journal of Emergency Medicine · 3
PDF
Works count: 36
Citation count: 1,383
H-index: 18
I10-index: 20
Year
Topic
Type